Individual Member

JANICE COWDEN

Diagnosed with Stage IV triple negative breast cancer in 2016, five years after an early-stage breast cancer diagnosis, Janice launched into patient advocacy following training through Living Beyond Breast Cancer’s Hear My Voice Outreach program in 2017. As a peer-to-peer support and research patient advocate, Janice is passionate about supporting others with metastatic breast cancer, in addition to continually furthering her scientific knowledge base of this disease, treatments, and clinical trials. Her professional life as a Pediatric nurse (retired) and Professional Pharmaceutical Sales Representative fuels her passion for scientific learning and dissemination of the most up to date disease-related information, which she acquires through attending evidence-based breast cancer conferences and webinars.

 

Janice works with several patient-founded and -led organizations including PCDI, GRASP, and Project Life MBC. As a trained peer support volunteer, she is founder of an international online peer support group for patients newly diagnosed with MBC.  She serves on the Board of Directors for METAvivor Research and Support, Inc., and is an Advisory Board member for Project Life MBC. In 2022, she attended ASCO as a patient advocate scholarship recipient. In October 2022, she was invited to serve as a lead patient advocate, representing PCDI, on a research study with ASCO. When she’s not busy with advocacy work, Janice enjoys traveling, reading, outdoor activities, and spending time with family, including her husband, two adult children and three grandchildren.

WHAT I'M WORKING ON

Clinical Trials

ASCO’s Clinical Trials Access and Participation Task Force

The ASCO Clinical Trials Access and Participation Task Force studies optimal dosing and alternate dosing strategies for treatments for patients with MBC. As a member of PCDI (Patient Centered Dosing Initiative), this research seeks to discover optimal dosing for patients, to help determine efficacy with fewer treatment-related side effects, and to improve quality of life for patients.

Link to program